• Welcome to Canada
  • Centrella
  • Mortara
  • Welch Allyn
  • Trumpf
  • Hill-Rom to Present at the Goldman Sachs 39th Annual Global Healthcare Conference

    CHICAGO, May 29, 2018 - Hill-Rom Holdings, Inc. (NYSE: HRC), today announced that it will present at the Goldman Sachs 39th Annual Global Healthcare Conference in Rancho Palos Verdes, California. Company leadership is scheduled to present on Tuesday, June 12, 2018, at 1:20 p.m. Pacific Time.

    Hill-Rom's Welch Allyn Home® Portfolio Debuts at All Kinney Drugs Locations

    CHICAGO, May 29, 2018 - Hill-Rom (NYSE: HRC) announced its Welch Allyn Home® Blood Pressure Monitors and Digital Scale are now available at all Kinney Drugs locations in New York and Vermont. The Welch Allyn Home portfolio is designed to bring the Welch Allyn clinical grade technology that doctors know and trust into the hands of consumers at home.

    Hill-Rom Inaugurates 100,000-Square-Foot Welch Allyn Campus Expansion

    SKANEATELES FALLS, N.Y., May 11, 2018 - Hill-Rom (NYSE: HRC) today celebrated the inauguration of its 100,000-square-foot Skaneateles Falls, NY, campus addition, which was recently completed and is already in use.

    Hill-Rom Declares Fiscal 2018 Third Quarter Dividend

    CHICAGO, May 10, 2018 - Hill-Rom Holdings, Inc. (NYSE: HRC), announced today that its board of directors declared a fiscal 2018 third quarter dividend of $0.20 per share payable on June 29, 2018, to shareholders of record as of the close of business on June 22, 2018. The indicated annual dividend rate is $0.80 per share.

    Siemens Healthineers and Hill-Rom to Provide Comprehensive Diabetes Care for Primary Care Facilities

    MALVERN, Pa., May 7, 2018 - Siemens Healthineers and Hill-Rom (NYSE: HRC) signed a co-marketing agreement to provide a suite of point-of-care diagnostic instruments that, for the first time, enable primary healthcare providers in the U.S. to bridge gaps in diabetes care and satisfy value-based quality measures in a single office visit. The integrated offering incorporates the Siemens Healthineers DCA Vantage® Analyzer for HbA1c testing, the CLINITEK Status®+ Urine Chemistry Analyzer for kidney checks, and Hill-Rom's Welch Allyn® RetinaVue™ Network and imaging technology for teleretinal exams.

    IMRIS and Hill-Rom Announce Commercial Launch of New Magnetic Resonance Neurosurgical Table

    CHICAGO, May 1, 2018 - IMRIS and Hill-Rom (NYSE: HRC) have commercially launched a new multi-functional operating room (OR) table specifically designed for the IMRIS Surgical Theatre. The announcement was made during the American Academy of Neurological Surgeons (AANS) Annual Scientific Meetingthis week in New Orleans.  

    Hill-Rom to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference

    CHICAGO, May 1, 2018 - Hill-Rom Holdings, Inc. (NYSE: HRC), announced today that Steve Strobel, senior vice president and chief financial officer, will present at the Bank of America Merrill Lynch 2018 Healthcare Conference on Tuesday, May 15, 2018, at 3:40 p.m. Pacific Time in Las Vegas.

    Hill-Rom Appoints John Groetelaars As President And Chief Executive Officer

    CHICAGO, April 27, 2018 - Hill-Rom Holdings, Inc. (NYSE: HRC), today announced that John P. Groetelaars has been appointed president and chief executive officer of the company, effective May 14, 2018. He succeeds John J. Greisch, who previously announced his intention to retire. Mr. Groetelaars will also join Hill-Rom's board of directors.